Uningwei announced that the company recently signed a partnership agreement with Changjiang Guohong and other parties to jointly fund the establishment of the Shanghai Guohong Medical Innovation and Intelligent Venture Capital Partnership. The total amount of pledged capital of the fund was 150 million yuan, and the company pledged an investment of 10 million yuan as a limited partner, accounting for 6.67%. The fund focuses on the healthcare industry, accounting for no less than 70% of the investment in the core sector. The term of existence is 7 years, and the funding payment period is no later than December 31, 2029. The current investment capital is its own capital, and the company bears the investment risk limited to the amount invested.

Uningwei announced that the company recently signed a partnership agreement with Changjiang Guohong and other parties to jointly fund the establishment of the Shanghai Guohong Medical Innovation and Intelligent Venture Capital Partnership. The total amount of pledged capital of the fund was 150 million yuan, and the company pledged an investment of 10 million yuan as a limited partner, accounting for 6.67%. The fund focuses on the healthcare industry, accounting for no less than 70% of the investment in the core sector. The term of existence is 7 years, and the funding payment period is no later than December 31, 2029. The current investment capital is its own capital, and the company bears the investment risk limited to the amount invested.